Journal Watch · Proceedings of the National Academy of Sciences (PNAS) · 2026

The revised three-step detour pathway in dolichol biosynthesis is evolutionarily conserved in budding yeast.

These findings show that Tda5 serves the same function as DHRSX in yeast, thereby demonstrating conservation of the three-step detour pathway in yeast and supporting a broader eukaryotic framework for dolichol biosynthesis.

Hanaoka K, Matsunaga K, Shimizu S et al.Proceedings of the National Academy of Sciences (PNAS)3 min readPharma relevance 65/100

DOI: 10.1073/pnas.2613147123PMID: 42201967Study type: clinical study

TL;DR

These findings show that Tda5 serves the same function as DHRSX in yeast, thereby demonstrating conservation of the three-step detour pathway in yeast and supporting a broader eukaryotic framework for dolichol biosynthesis.

Key findings

  • Deletion of <i>TDA5</i> caused glycosylation defects, reduced dolichol levels, and accumulated polyprenol.
  • All these phenotypes were rescued by expression of <i>DHRSX</i>, but not by <i>DFG10</i> or <i>SRD5A3</i>.
  • These findings show that Tda5 serves the same function as DHRSX in yeast, thereby demonstrating conservation of the three-step detour pathway in yeast and supporting a broader eukaryotic framework for dolichol biosynthesis.

What they did

However, it remains unclear whether this pathway represents a conserved mechanism or reflects evolutionary diversity in eukaryotes. Here, we identified <i>TDA5</i> as a yeast ortholog of <i>DHRSX</i>.

Full abstract (original)

Background: The identification of <i>SRD5A3</i>, a causative gene for congenital disorders of glycosylation (CDGs), together with its yeast ortholog <i>DFG10</i>, established the prevailing model that dolichol is synthesized from polyprenol in a single step. Subsequently, a recent discovery of DHRSX in CDG patients revised this view and led to the proposal of a three-step detour pathway for dolichol biosynthesis.

What they did: However, it remains unclear whether this pathway represents a conserved mechanism or reflects evolutionary diversity in eukaryotes. Here, we identified <i>TDA5</i> as a yeast ortholog of <i>DHRSX</i>.

Results & conclusions: Deletion of <i>TDA5</i> caused glycosylation defects, reduced dolichol levels, and accumulated polyprenol. All these phenotypes were rescued by expression of <i>DHRSX</i>, but not by <i>DFG10</i> or <i>SRD5A3</i>. These findings show that Tda5 serves the same function as DHRSX in yeast, thereby demonstrating conservation of the three-step detour pathway in yeast and supporting a broader eukaryotic framework for dolichol biosynthesis.

Abstract © the authors / Proceedings of the National Academy of Sciences (PNAS) (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1073/pnas.2613147123 · PubMed 42201967.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Proceedings of the National Academy of Sciences (PNAS) for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Proceedings of the National Academy of Sciences (PNAS) study find?

These findings show that Tda5 serves the same function as DHRSX in yeast, thereby demonstrating conservation of the three-step detour pathway in yeast and supporting a broader eukaryotic framework for dolichol biosynthesis.

What type of study is this?

It is a clinical study, published in Proceedings of the National Academy of Sciences (PNAS) in 2026. However, it remains unclear whether this pathway represents a conserved mechanism or reflects evolutionary diversity in eukaryotes.

Where can I read the original paper?

The original is at the publisher via DOI 10.1073/pnas.2613147123. PubMed ID: 42201967. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Hanaoka K, Matsunaga K, Shimizu S et al.. The revised three-step detour pathway in dolichol biosynthesis is evolutionarily conserved in budding yeast.. Proceedings of the National Academy of Sciences (PNAS) (2026). DOI: 10.1073/pnas.2613147123.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/the-revised-three-step-detour-pathway-in-dolichol-biosynthesis-is-evolut-147123/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides